Brief: Corline Biomedical Q2 Loss SEK 3.3 Mln
Aug 26 (Reuters) - Corline Biomedical AB CLBIO.ST: Q2 REPORTS NET SALES OF 2,187 KSEK, RESULT -3,257 KSEK Source text: ID:nGNEKzd8H Further company coverage: CLBIO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln